We present the Early Cancer Institute Annual Symposium 2024, #ECISymposium2024
The event is aimed at scientists of all levels, clinicians and industry representatives with an interest in early cancer research. It will be a fantastic opportunity to hear from a range of speakers, learn about new developments in this field and get an update on the Institute's achievements and future plans.
Keynote Speakers
PD Dr. med. Titus J. Brinker
Research Group Leader, Digital Biomarkers for Oncology, German Cancer Research Center (DKFZ), Heidelberg
'The era of interpretable AI in cancer prevention and early detection'
Prof Simon Leedham
Professor of Molecular and Population Genetics and an Honorary Consultant Gastroenterologist at the University of Oxford
There will be short talks from our newest group leaders: Siddhartha Kar, Mireia Crispin, Danielle Harper
We are also excited to have a number of 'Lightning Talks' and the opportunity to present a poster.
Following the talks there will be ample opportunity to network with other attendees over refreshments.
Abstract Submissions
We invite PhD students, postdocs, junior group leaders and other researchers involved in all aspects of early cancer research to submit abstracts to be considered for a lightning talk and/or a poster presentation at the event.
Each lightning talk will be 7 minutes in duration followed by a 3-minute Q&A and will form part of the main symposium programme.
For further details of how to submit an abstract please see our Abstract Submission Guidelines
The submission deadline is Sunday 25th August 2024.
Speaker Biographies
Titus Brinker is the head of the Junior Research Group ‘Digital Biomarkers for Oncology’ and clinician scientist at the German Cancer Research Center (DKFZ) where his research programme is focused on cancer prevention, early diagnosis, and improved therapy control via digital approaches. Dr Brinker has developed a number of digital apps for smoking and melanoma prevention. His group has expertise in the image classification domain with a particular focus on skin, colorectal, prostate and breast cancer. Titus’ pioneering work in leveraging AI technology to improve early detection methods for skin cancer has earned him many awards including the ‘Vision-Zero’ Innovation Award and AI Champions Baden-Württemberg 2023.
Simon Leedham is a Professor of Molecular and Population Genetics and an Honorary Consultant Gastroenterologist at the University of Oxford. His research is into the morphogenic signalling pathways that control the intestinal stem cell in homeostasis, regeneration and cancer, and he has published more than 100 peer reviewed papers in journals that include Nature, Nature Medicine, Nature Genetics, Cell Stem Cell, Gastroenterology and Gut. Simon’s research has been recognised by the United European Gastroenterology Rising Star award in 2010, the British Society of Gastroenterology Francis Avery Jones research prize in 2015 and the CRUK Future Leaders prize in 2017.
